Skip to content

Early Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year

Early Neonatal Respiratory Distress: Changes in Level IIb Hospital Over a Period of One Year

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02824497
Acronym
DROPE
Enrollment
100
Registered
2016-07-06
Start date
2015-05-31
Completion date
2015-05-31
Last updated
2023-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Respiratory Distress Syndrome

Brief summary

Respiratory distress is one of the first hospital grounds during the neonatal period. The clinical presentation and severity vary by gestational age and cause. She reports to various etiological factors as maternal, neonatal or sometimes entangled. The symptomatic management has benefited from organizational progress (perinatal care) and techniques, including antenatal steroids, the use of exogenous surfactant and non-invasive ventilation early, so that the use of intubation is less frequent. The short-term evolution of patients with early respiratory distress is based on gestational age, cause and initial management.

Detailed description

Main objective: To describe the care and short-term respiratory become newborns 32 weeks gestation or older with early and persistent respiratory distress to 2 hours of life (H2) over a period of one year in a type IIb motherhood. Methodology : Design: retrospective, descriptive, single-center, non-interventional Performed in the Saint Joseph neonatal unit. Study duration: 1 year (01/05/2013-04/30/2014). Acquisition of data: The patients were selected from the hospitalization reports of infants by taking the following key words: respiratory distress, invasive and noninvasive ventilation, intubation, exogenous surfactant, pneumothorax. Data collected: * Obstetric data: * Mode of delivery: route of delivery, presentation at birth. * Maternal morbidity. * antenatal corticosteroids in infants less than 34 weeks. * Neonatal data: * Gestational Age * Birth Weight * cord pH * Apgar M5 * The terms of the allocation: * Tracheal Intubation * ventilation modes (controlled mechanical ventilation (VMC), non-invasive ventilation (NIV), nasal cannula), the maximum reached FiO2 (fraction of inspired oxygen), ventilation time for each ventilation mode. These different methods were studied in the delivery room during hospitalization (in intensive care and neonatal intensive care NICU). * The place of hospitalization: resuscitation and / or NICU. * The transfer to the NICU resuscitation if necessary. * Received drugs (exogenous surfactant, antibiotics, caffeine) * The successful primary diagnosis.

Interventions

OTHERNo intervention. It's a description study

Sponsors

Fondation Hôpital Saint-Joseph
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
32 Weeks to 40 Weeks
Healthy volunteers
No

Inclusion criteria

* Gestational Age (A) ≥ 32 SA * Birth weight (PN) ≥ 1000 g * Respiratory distress appeared in the first 2 of life and non-limiting in H2.

Exclusion criteria

* AG \<32 SA * PN \<1000g * Malformation diagnosed ante or immediate postpartum justifying a specific urgent care. * Respiratory distress appeared before H2 and H2-limited before, whatever the company therapeutic. * Respiratory distress appeared after H2.

Design outcomes

Primary

MeasureTime frameDescription
Obstetric dataDay 0Number of Participants With same characteristics for: * Mode of delivery: route of delivery, presentation at birth. * Maternal morbidity. * antenatal corticosteroids in infants less than 34 weeks.

Secondary

MeasureTime frameDescription
Neonatal dataDay 0Number of Participants With same characteristics for: * Gestational Age * Birth Weight * cord pH * Apgar M5
The terms of the allocation:Day 0Number of Participants With same characteristics for: * Tracheal Intubation * ventilation modes (controlled mechanical ventilation (VMC), non-invasive ventilation (NIV), nasal cannula), the maximum reached FiO2, ventilation time for each ventilation mode. These different methods were studied in the delivery room during hospitalization (in intensive care and neonatal intensive care NICU) * The place of hospitalization: resuscitation and / or NICU. * The transfer to the NICU resuscitation if necessary. * Received drugs (exogenous surfactant, antibiotics, caffeine) * The successful primary diagnosis.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026